Since then, our labs and others have elucidated mutation mechanisms activated by stress responses.
This mutation activates AKT by means of pathological localization to the plasma membrane, stimulates downstream signaling, transforms cells and induces leukemia in mice [9].
This contrasts with what has been observed for mutations in the ATP-binding site that completely abolished ATP inhibition in the absence of Mg2+, such as R50P and G334D: channels containing these mutations were activated by MgATP [ 33, 34].
Altogether, these data suggested that the c.903+469T>C mutation activates the pseudoexon by strengthening and/or creating an ESE, which potentially could function by binding of the splicing factor SF2/ASF.
In addition, the buried mutations are not activated by AdoMet (the median activation of buried mutations of 1.0 × contrasts with the 2.5 × activation of solvent exposed mutation) and seem to be inhibited by AdoHcy (median activation of buried mutations is 0.8 ×, while it is 1.3 × for solvent-exposed mutations).
For example, oncogenic activation of the RAS genes by point mutation activates the pathway via the interaction of RAS with p110α, the catalytic subunit of PI3 kinase [ 10].
Furthermore, activation of receptor tyrosine kinase (RTK) signaling by either the ligand or by a mutation activating the receptor constitutively leads to EMT [ 7].
Resistance occurs secondary to emergence of AR somatic point mutations that are activated by prednisolone but not by dexamethasone.
In addition to point mutations, PDGFRA is activated by other mechanisms such as gene amplification in glioblastoma and chromosomal translocation leading to fusion protein formation in certain myeloproliferative diseases (Fletcher, 2004).
In colon cancer, the WNT pathway is commonly activated by mutations in the mutation cluster region of APC.
